Nearly 6.7 million adults in the U.S. have heart failure, with prevalence expected to rise to 8.5 million by 20301,2. While heart failure is a chronic, progressive disease, advances in technology are ...

One of the benefits of interventional cardiology fellowship training is the exposure to new technology. Two newly approved devices—the CardioMems heart failure monitoring system (St Jude Medical) and ...

Using the device also seems to cut rates of HF hospitalization compared with the two comparator groups (P<0.01 and P<0.0001, respectively), Dr Nirav Raval (Florida Hospital Transplant Institute, ...

The CardioMEMS HF System is proven to significantly reduce heart failure hospitalizations and improve quality of life in NYHA class III HF patients St. Jude Medical now intends to exercise its ...

St. Jude Medical has been working for a couple of years to make the case for its tiny implantable heart failure monitor CardioMEMS--without much sales success thus far. But it gained a bit more fodder ...

St. Jude Medical was confident that a novel cardiac device with proven outcomes would be adopted quickly, but is facing reimbursement's unrelenting brick wall. Arundhati Parmar Sometimes the best laid ...